Impact of vaccination on COVID‐19 outcome in multiple sclerosis

BACKGROUND AND PURPOSE: COVID‐19 continues to challenge neurologists in counseling persons with multiple sclerosis (pwMS) regarding disease‐modifying treatment (DMT) and vaccination. The objective here was to characterize predictors of COVID‐19 outcome in pwMS. METHODS: We included pwMS with polymer...

Descripción completa

Detalles Bibliográficos
Autores principales: Bsteh, Gabriel, Gradl, Christiane, Heschl, Bettina, Hegen, Harald, Di Pauli, Franziska, Assar, Hamid, Leutmezer, Fritz, Traxler, Gerhard, Krajnc, Nik, Zulehner, Gudrun, Hiller, Maria‐Sophia, Rommer, Paulus, Wipfler, Peter, Guger, Michael, Enzinger, Christian, Berger, Thomas, Aigner, Doris, Böck, Klaus, Bsteh, Christian, Gruber, Elisabeth, Hiller, Marie‐Sophie, Kornek, Barbara, Lex, Camillo, Mayr, Markus, Morgenstern, Gabriele, Oel, Dirk, Schnabl, Peter, Schneider‐Koch, Gabriela, Schrotter, Gabriele, Zrzavy, Tobias
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350380/
https://www.ncbi.nlm.nih.gov/pubmed/35791496
http://dx.doi.org/10.1111/ene.15488

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9350380/
https://www.ncbi.nlm.nih.gov/pubmed/35791496
http://dx.doi.org/10.1111/ene.15488

Ejemplares similares